Growth Clinical Trial
Official title:
An Open Label Clinical Study to Evaluate Growth and Safety of a Low Lactose Milk-Based Infant Formula in Healthy Term Infants
| Verified date | May 2013 |
| Source | Perrigo Nutritionals |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The purpose of this study is to show that a low lactose milk-based infant formula supports normal growth in healthy term infants.
| Status | Completed |
| Enrollment | 85 |
| Est. completion date | March 2013 |
| Est. primary completion date | March 2013 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | N/A to 14 Days |
| Eligibility |
Inclusion Criteria: - healthy term infants - birth weight 2500 - 4500 g - singleton birth - 37 - 42 weeks gestation Exclusion Criteria: - clinically significant abnormal findings (as determined by the investigator) on the physical examination or medical history - receiving medications other than vitamins |
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| United States | PI-Coor Research | Burke | Virginia |
| United States | Research Across America | Dallas | Texas |
| United States | ACC Pediatric Research | Haughton | Louisiana |
| United States | Center for Pharmaceutical Research | Kansas City | Missouri |
| United States | Accelovance Melbourne Site | Melbourne | Florida |
| United States | Jean Brown Research | Murray | Utah |
| Lead Sponsor | Collaborator |
|---|---|
| Perrigo Nutritionals |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Weight | 16 weeks | No | |
| Secondary | Length gain | 16 weeks | No | |
| Secondary | Occipital Head Circumference | 16 weeks | No | |
| Secondary | Acceptability and Tolerability | Assessed by digestive tolerance; general health and well-being; adverse events; concomitant medications | 16 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05551975 -
Preterm Infants Fed a Human Milk Fortifier
|
N/A | |
| Completed |
NCT01721512 -
The Growth and Development of Breast and Formula Fed Term Asian Infants
|
N/A | |
| Completed |
NCT01162798 -
Preterm Infant Growth
|
N/A | |
| Active, not recruiting |
NCT00970398 -
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
|
N/A | |
| Completed |
NCT01666457 -
Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)
|
||
| Completed |
NCT00808756 -
Study on Fermentable Carbohydrates in Healthy Infants
|
N/A | |
| Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
| Completed |
NCT03276663 -
Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula
|
N/A | |
| Recruiting |
NCT02695784 -
Probiotics After Discharge
|
Phase 4 | |
| Withdrawn |
NCT02860026 -
Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas
|
N/A | |
| Completed |
NCT01128517 -
Maternal Education on Complementary Feeding and Infant Outcome
|
N/A | |
| Completed |
NCT00282113 -
Effects of Probiotic and Prebiotic Combinations on Premature Infants
|
N/A | |
| Completed |
NCT03276884 -
Growth and Tolerance of Young Infants
|
N/A | |
| Completed |
NCT04055363 -
Human Milk Oligosaccharides (HMOs) Post-market Study on Infants
|
N/A | |
| Completed |
NCT05302427 -
Infant Massage and Infant Growth, Mother-Infant Attachment, and Maternal Self-Confidence
|
N/A | |
| Not yet recruiting |
NCT05616117 -
Next-generation Effects of Vitamin D Supplementation in Pregnancy
|
||
| Active, not recruiting |
NCT02410057 -
Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula
|
N/A | |
| Completed |
NCT01210391 -
Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
|
N/A | |
| Completed |
NCT01109849 -
Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth
|
Phase 4 | |
| Completed |
NCT01158352 -
Study to Evaluate the Effect of Short Treatment With Nutritional Supplementation Standardized Innovative Formula, on Growth and Weight Gain in Short and Lean Prepubertal Children
|
N/A |